Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
University of California, Davis
156 participants
Dec 7, 2019
INTERVENTIONAL
Conditions
Summary
Magnesium is a naturally occurring mineral that is important for your body and brain. Magnesium sulfate (study drug) is a medication containing magnesium that is commonly used to improve low blood levels of magnesium. Magnesium sulfate has also proven to be successful in managing pain before and after surgery. However, this drug has primarily been used for pain control in patients undergoing surgery. Patients in the ICU with injuries also need good pain control. Using magnesium may assist in decreasing narcotic (pain reliever) requirements and provide another non-narcotic drug for pain control. The purpose of this study is to test the effectiveness of continuous, intravenous (into or within a vein using a needle) administration of magnesium sulfate for pain control in trauma patients admitted to the adult Intensive Care Unit. This will be compared to intravenous normal saline (salt solution).
Eligibility
Inclusion Criteria4
- All trauma patients admitted to an adult intensive care unit
- Signed informed consent
- Hospital or trauma multimodal pain management order set used for pain management
- Ages 18-99
Exclusion Criteria14
- Admission to the Pediatric Intensive Care Unit.
- Head Abbreviated Injury Score (AIS) of greater than 1
- Known heart failure with reduced ejection fraction (EF < 40%)
- Renal failure (GFR < 60)
- Cardiac arrhythmia (except for sinus tachycardia)
- Greater than 5% TBSA burn injuries
- Moderate to severe alcohol withdrawal protocol ordered for patient
- Regular use of opioids in the week prior to injury
- Receiving continuous infusion of opioids
- Patients expected to require general anesthesia between 24 and 48 hours after admission (during study drug administration)
- Patients unable to provide consent is unavailable
- Patients unable to provide a pain score
- Pregnancy
- Prisoners
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
IV bolus followed by continuous infusion for 24 hours
IV bolus followed by continuous infusion for 24 hours
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04166877